116 related articles for article (PubMed ID: 11142650)
1. A peripheral, intracerebral, or intrathecal administration of an opioid receptor antagonist blocks illness-induced hyperalgesia in the rat.
McNally GP; Johnston IN; Westbrook RF
Behav Neurosci; 2000 Dec; 114(6):1183-90. PubMed ID: 11142650
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of morphine analgesia by lithium: role of peripheral and central opioid receptors.
Johnston IN; Westbrook RF
Behav Brain Res; 2004 May; 151(1-2):151-8. PubMed ID: 15084430
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of morphine analgesia by LPS: role of opioid and NMDA receptors and spinal glia.
Johnston IN; Westbrook RF
Behav Brain Res; 2005 Jan; 156(1):75-83. PubMed ID: 15474652
[TBL] [Abstract][Full Text] [Related]
4. Analgesic effects of systemic fentanyl on cancer pain are mediated by not only central but also peripheral opioid receptors in mice.
Shinohara A; Andoh T; Saiki I; Kuraishi Y
Eur J Pharmacol; 2018 Aug; 833():275-282. PubMed ID: 29886241
[TBL] [Abstract][Full Text] [Related]
5. Role of central versus peripheral opioid receptors in analgesia induced by repeated administration of opioid antagonists.
Walker MJ; Lê AD; Poulos CX; Cappell H
Psychopharmacology (Berl); 1991; 104(2):164-6. PubMed ID: 1652143
[TBL] [Abstract][Full Text] [Related]
6. Differential actions of intrathecal naloxone on blocking the tail-flick inhibition induced by intraventricular beta-endorphin and morphine in rats.
Tseng LF; Fujimoto JM
J Pharmacol Exp Ther; 1985 Jan; 232(1):74-9. PubMed ID: 3155550
[TBL] [Abstract][Full Text] [Related]
7. Differential actions of the blockade of spinal opioid, adrenergic and serotonergic receptors on the tail-flick inhibition induced by morphine microinjected into dorsal raphe and central gray in rats.
Tseng LL; Tang R
Neuroscience; 1989; 33(1):93-100. PubMed ID: 2557562
[TBL] [Abstract][Full Text] [Related]
8. Subcutaneous, intrathecal and periaqueductal grey administration of asimadoline and ICI-204448 reduces tactile allodynia in the rat.
Caram-Salas NL; Reyes-García G; Bartoszyk GD; Araiza-Saldaña CI; Ambriz-Tututi M; Rocha-González HI; Arreola-Espino R; Cruz SL; Granados-Soto V
Eur J Pharmacol; 2007 Nov; 573(1-3):75-83. PubMed ID: 17643411
[TBL] [Abstract][Full Text] [Related]
9. Antihypersensitivity effects of tramadol hydrochloride in a rat model of postoperative pain.
Kimura M; Obata H; Saito S
Anesth Analg; 2012 Aug; 115(2):443-9. PubMed ID: 22575568
[TBL] [Abstract][Full Text] [Related]
10. Peripheral and spinal actions of opioids in the blockade of the autonomic response evoked by compression of the inflamed knee joint.
Nagasaka H; Awad H; Yaksh TL
Anesthesiology; 1996 Oct; 85(4):808-16. PubMed ID: 8873551
[TBL] [Abstract][Full Text] [Related]
11. 5-HT spinal antinociception involves mu opioid receptors: cross tolerance and antagonist studies.
Goodchild CS; Guo Z; Freeman J; Gent JP
Br J Anaesth; 1997 May; 78(5):563-9. PubMed ID: 9175973
[TBL] [Abstract][Full Text] [Related]
12. Delayed postoperative latent pain sensitization revealed by the systemic administration of opioid antagonists in mice.
Campillo A; Cabañero D; Romero A; García-Nogales P; Puig MM
Eur J Pharmacol; 2011 Apr; 657(1-3):89-96. PubMed ID: 21300053
[TBL] [Abstract][Full Text] [Related]
13. Increased release of immunoreactive cholecystokinin octapeptide by morphine and potentiation of mu-opioid analgesia by CCKB receptor antagonist L-365,260 in rat spinal cord.
Zhou Y; Sun YH; Zhang ZW; Han JS
Eur J Pharmacol; 1993 Apr; 234(2-3):147-54. PubMed ID: 8387008
[TBL] [Abstract][Full Text] [Related]
14. Lumbar intrathecal naloxone blocks analgesia produced by microstimulation of the ventromedial medulla in the rat.
Zorman G; Belcher G; Adams JE; Fields HL
Brain Res; 1982 Mar; 236(1):77-84. PubMed ID: 6279238
[TBL] [Abstract][Full Text] [Related]
15. Intrathecal high dose morphine produces hyperalgesia in the rat.
Woolf CJ
Brain Res; 1981 Mar; 209(2):491-5. PubMed ID: 6261872
[TBL] [Abstract][Full Text] [Related]
16. Comparative study of the analgesic and paralytic effects induced by intrathecal dynorphin a in rats.
Xue JC; Yu YX; Han JS; Jen MF
Int J Neurosci; 1995 May; 82(1-2):83-93. PubMed ID: 7591518
[TBL] [Abstract][Full Text] [Related]
17. Differential antinociceptive effects induced by intrathecally administered endomorphin-1 and endomorphin-2 in the mouse.
Sakurada S; Hayashi T; Yuhki M; Orito T; Zadina JE; Kastin AJ; Fujimura T; Murayama K; Sakurada C; Sakurada T; Narita M; Suzuki T; Tan-no K; Tseng LF
Eur J Pharmacol; 2001 Sep; 427(3):203-10. PubMed ID: 11567650
[TBL] [Abstract][Full Text] [Related]
18. Activity at phencyclidine and mu opioid sites mediates the hyperalgesic and antinociceptive properties of the N-terminus of substance P in a model of visceral pain.
Goettl VM; Larson AA
Neuroscience; 1994 May; 60(2):375-82. PubMed ID: 7521022
[TBL] [Abstract][Full Text] [Related]
19. Central administration of oxytocin reduces hyperalgesia in mice: implication for cannabinoid and opioid systems.
Russo R; D'Agostino G; Mattace Raso G; Avagliano C; Cristiano C; Meli R; Calignano A
Peptides; 2012 Nov; 38(1):81-8. PubMed ID: 22917880
[TBL] [Abstract][Full Text] [Related]
20. Endogenous opioid mechanisms partially mediate P2X3/P2X2/3-related antinociception in rat models of inflammatory and chemogenic pain but not neuropathic pain.
McGaraughty S; Honore P; Wismer CT; Mikusa J; Zhu CZ; McDonald HA; Bianchi B; Faltynek CR; Jarvis MF
Br J Pharmacol; 2005 Sep; 146(2):180-8. PubMed ID: 16041397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
